Načítá se...
Considerations for designing preclinical studies in cancer immune nanomedicine
Immunotherapy is known to be clinically beneficial for patients with cancer and has in many cases become the new standard of care. Because of this success, the interest in integrating nanomedicine with cancer immunotherapy has grown to further improve clinical response and toxicity profiles. However...
Uloženo v:
| Vydáno v: | Nat Nanotechnol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103921/ https://ncbi.nlm.nih.gov/pubmed/33349682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41565-020-00817-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|